T1	Participants 10 30	patients with asthma
T2	Participants 765 856	Patients with asthma stabilized on CFC albuterol during a 12-week safety and efficacy trial
T3	Participants 1049 1179	12 weeks of the yearlong trial between patients who had remained on CFC albuterol and those who had been switched to HFA albuterol
